packageRavidasvir

ravidasvir

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Ravidasvir is an investigational antiviral drug studied for the treatment of hepatitis C virus infections. It is not an approved medicine and remains under investigation, with no marketing authorisation in the European Union.

Summary written by glm-5.3-flash from Wikidata Q25101668 and the WHO ATC classification; not checked by a person.

name:ravidasvir
ATC codes:J05AP13
DrugBank:DB15652
PubChem CID:52918888
Wikidata:Q25101668
formula:C42H50N8O6
molar mass:762.912 g/mol (PubChem CID 52918888)
logP:6.1 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown